MX337048B - Vacuna marcadora para la fiebre porcina clasica. - Google Patents

Vacuna marcadora para la fiebre porcina clasica.

Info

Publication number
MX337048B
MX337048B MX2012013419A MX2012013419A MX337048B MX 337048 B MX337048 B MX 337048B MX 2012013419 A MX2012013419 A MX 2012013419A MX 2012013419 A MX2012013419 A MX 2012013419A MX 337048 B MX337048 B MX 337048B
Authority
MX
Mexico
Prior art keywords
swine fever
classical swine
marker vaccine
relates
marker
Prior art date
Application number
MX2012013419A
Other languages
English (en)
Other versions
MX2012013419A (es
Inventor
Martin Beer
Sandra Blome
Immanuel Leifer
Original Assignee
Riemser Arzneimittel Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riemser Arzneimittel Ag filed Critical Riemser Arzneimittel Ag
Publication of MX2012013419A publication Critical patent/MX2012013419A/es
Publication of MX337048B publication Critical patent/MX337048B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/29—Hepatitis virus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C07K14/08—RNA viruses
    • C07K14/18—Togaviridae; Flaviviridae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6081—Albumin; Keyhole limpet haemocyanin [KLH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

La presente invención se refiere a una vacuna marcadora para el tratamiento profiláctico de la fiebre porcina clásica que comprende el virus vivo modificado atenuado de la fiebre porcina clásica. La secuencia viral de aminoácidos del epítope TAV de la proteína E2 comprende una secuencia diferente de la de un virus de tipo silvestre de la fiebre porcina clásica. La invención se refiere a composiciones farmacéuticas de la vacuna marcadora. La invención también se refiere a un procedimiento para fabricar las vacunas marcadoras para la prevención de la fiebre porcina clásica usando presión selectiva de anticuerpos.
MX2012013419A 2010-05-18 2011-05-18 Vacuna marcadora para la fiebre porcina clasica. MX337048B (es)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
EP10075207 2010-05-18
EP10075206 2010-05-18
DE102010017006 2010-05-18
EP10075205 2010-05-18
EP10075760 2010-12-17
EP10075759 2010-12-17
EP11159207 2011-03-22
PCT/EP2011/002624 WO2011144360A1 (en) 2010-05-18 2011-05-18 Marker vaccine for classical swine fever

Publications (2)

Publication Number Publication Date
MX2012013419A MX2012013419A (es) 2013-01-28
MX337048B true MX337048B (es) 2016-02-11

Family

ID=44461927

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012013419A MX337048B (es) 2010-05-18 2011-05-18 Vacuna marcadora para la fiebre porcina clasica.

Country Status (20)

Country Link
US (1) US9315873B2 (es)
EP (1) EP2571519B1 (es)
KR (1) KR101845571B1 (es)
CN (1) CN102905725B (es)
BR (1) BR112012029145B8 (es)
CA (1) CA2801897C (es)
CY (1) CY1118060T1 (es)
DK (1) DK2571519T3 (es)
EA (1) EA031518B1 (es)
ES (1) ES2593965T3 (es)
HR (1) HRP20161225T1 (es)
HU (1) HUE029385T2 (es)
MX (1) MX337048B (es)
PH (1) PH12012502273A1 (es)
PL (1) PL2571519T3 (es)
PT (1) PT2571519T (es)
RS (1) RS55214B1 (es)
SI (1) SI2571519T1 (es)
WO (1) WO2011144360A1 (es)
ZA (1) ZA201208194B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103159858B (zh) * 2013-02-26 2014-06-04 中国农业科学院上海兽医研究所 猪瘟分支肽及其应用
ES2757927T3 (es) * 2014-05-23 2020-04-30 Boehringer Ingelheim Vetmedica Gmbh Virus de la peste porcina clásica (VPPC) recombinante que comprende sustituciones en el epítopo TAV de la proteína E2
CN118620043B (zh) * 2024-06-11 2024-11-15 宁夏农林科学院动物科学研究所(宁夏草畜工程技术研究中心) 双价牛病毒性腹泻病毒e2亚单位疫苗、制备方法及应用
CN121021653B (zh) * 2025-10-30 2026-04-03 吉林大学 猪瘟病毒e2蛋白标记亚单位疫苗及其配套的血清学鉴别诊断试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ287563A (en) * 1994-06-17 1998-08-26 Inst Veehouderij Diergezondh Dna sequence of classical swine fever virus (csfv), vaccine and diagnostic test
US8846055B2 (en) 2006-05-30 2014-09-30 The United States Of America, As Represented By The Secretary Of Agriculture Virulence determinant within the E2 structural glycoprotein of classical swine fever virus
US8133495B2 (en) * 2007-05-22 2012-03-13 The United States Of America As Represented By The Secretary Of Agriculture Live attenuated antigenically marked classical swine fever virus
EP2202298A1 (en) * 2008-12-23 2010-06-30 Stichting Dienst Landbouwkundig Onderzoek Recombinant classical swine fever virus (CSFV) comprising a modified E2 protein and methods for generating said recombinant CSFV

Also Published As

Publication number Publication date
CN102905725A (zh) 2013-01-30
CA2801897A1 (en) 2011-11-24
MX2012013419A (es) 2013-01-28
BR112012029145B8 (pt) 2022-03-08
RS55214B1 (sr) 2017-02-28
ZA201208194B (en) 2014-01-29
ES2593965T3 (es) 2016-12-14
CN102905725B (zh) 2016-01-20
BR112012029145A2 (pt) 2020-07-07
KR101845571B1 (ko) 2018-04-04
KR20130109008A (ko) 2013-10-07
SI2571519T1 (sl) 2017-01-31
US20130129762A1 (en) 2013-05-23
PH12012502273A1 (en) 2013-02-04
PT2571519T (pt) 2016-10-03
WO2011144360A1 (en) 2011-11-24
EP2571519A1 (en) 2013-03-27
HUE029385T2 (en) 2017-02-28
HRP20161225T1 (hr) 2016-12-02
DK2571519T3 (en) 2016-10-17
EA201270794A1 (ru) 2013-04-30
CY1118060T1 (el) 2017-06-28
EP2571519B1 (en) 2016-06-29
EA031518B1 (ru) 2019-01-31
BR112012029145B1 (pt) 2021-09-14
EA201270794A8 (ru) 2017-10-31
CA2801897C (en) 2019-01-15
US9315873B2 (en) 2016-04-19
PL2571519T3 (pl) 2017-07-31

Similar Documents

Publication Publication Date Title
AU2014310935B2 (en) Combination vaccine
PH12018500916A1 (en) Antibody neutralizing human respiratory syncytial virus
WO2013120628A8 (en) Nucleic acid comprising or coding for a histone stem-loop and a poly(a) sequence or a polyadenylation signal for increasing the expression of an encoded pathogenic antigen
WO2012027365A3 (en) Targeted multi-epitope dosage forms for induction of an immune response to antigens
PH12013501683A1 (en) Yeast-based therapeutic for chronic hepatitis b infection
BR112013011194A2 (pt) partículas de glicoproteína semelhantes a vírus (vlps) da raiva.
WO2007095318A3 (en) Influenza antigens, vaccine compositions, and related methods
MX347997B (es) Vacunas aviares vectorizadas con el virus de la enfermedad de newcastle.
PH12017501370A1 (en) Bivalent swine influenza virus vaccine
WO2013106834A3 (en) Immunogenic wt-1 peptides and methods of use thereof
PH12013502442A1 (en) Inactivated dengue virus vaccine
WO2014150822A3 (en) Porcine reproductive and respiratory syndrome virus, compositions, vaccine and methods of use
MX2013004159A (es) Proteina vp6 de la capside de norovirus y de rotavirus para el uso como vacuna combinada.
MX344103B (es) Vacunas de virus herpes vectorizado con virus de enfermedad de newcastle.
EA201490654A1 (ru) Новые ингибиторы вирусной репликации
AU2014232363A8 (en) Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
MY179251A (en) Methods and compositions for recombinant dengue viruses for vaccine and diagnostic development
MX2015013304A (es) Vacunas de nucleoproteina de la influenza.
MX2019007924A (es) Vacunas contra la influenza.
EA201500140A1 (ru) Ослабленные вакцины от свиного гриппа и способы их получения и применения
PH12012502273A1 (en) Marker vaccine for classical swine fever
PH12017501100A1 (en) Recombinant swinepox virus and vaccines
BR112012029633A8 (pt) Vetores do parapoxvírus contendo antígeno do vírus da raiva.
IN2014DN09445A (es)
EP4477231A3 (en) Combination vaccine

Legal Events

Date Code Title Description
FG Grant or registration